Advanced disease with minimal remaining tissue: Limited peptide benefit potential
If a patient is deficient in Folic Acid, it causes nerve damage & numbness of limbs (Peripheral Neuropathy)
Disclosure of interest: Name of author: nothing to disclose Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P254 - ESOC25-701 PILS-STROKE: DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FOR MEASURING POST-STROKE PARTICIPATION Edouard Ducoffre 1,2 , Camille Van Hentenryck 1 , Merlin Somville 2 , Zlie Rosselli 2 , Geoffroy Saussez 1 , Yannick Bleyenheuft 2 , Carlyne Arnould 1 1 Health and medical technologies department, CeREF-Sant - Haute Ecole Louvain en Hainaut, Montignies-sur-Sambre, Belgium, 2 Institute of Neuroscience, Universit Catholique de Louvain (UCLouvain), Brussels, Belgium Background and Aims: Participation is an ultimate goal of rehabilitation, given its impact on patients quality of life
A BPC-157 5 mg + TB-500 5 mg blend combines both peptides into one product for convenience and simplified peptide management
OCEAN PHARMACEUTICAL is one of Trade India's verified and trusted sellers of listed products
